Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.34 |
| ▸ | CDC14B | O60729 | 2/20 | 0.33 |
| ▸ | CDC14A | Q9UNH5 | 2/20 | 0.33 |
| ▸ | WEE1 | P30291 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.30 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26433291 | 0.97 | CDC14B (0.34) | ALOX5CDC14BCDC14AWEE1 | |
| SCHEMBL26433316 | 0.95 | ALOX5 (0.41) | ALOX5CDC14BCDC14AWEE1 | |
| SCHEMBL26433574 | 0.93 | ALOX5 (0.43) | ALOX5CDC14BCDC14AWEE1MAPT | |
| SCHEMBL26434175 | 0.93 | ALOX5 (0.42) | ALOX5CDC14BCDC14AWEE1PLA2G2A | |
| SCHEMBL26433340 | 0.92 | ALOX5 (0.32) | ALOX5CDC14BCDC14AWEE1 | |
| SCHEMBL25020482 | 0.91 | PLA2G2A (0.32) | ALOX5CDC14BCDC14AWEE1MAPT | |
| SCHEMBL26432760 | 0.91 | PLA2G2A (0.32) | ALOX5CDC14BCDC14AWEE1MAPT | |
| SCHEMBL26433441 | 0.91 | ALOX5 (0.33) | ALOX5CDC14BCDC14AMAPT | |
| SCHEMBL26432539 | 0.90 | PLA2G2A (0.33) | ALOX5CDC14BCDC14AWEE1MAPT | |
| SCHEMBL26432763 | 0.90 | PLA2G2A (0.33) | ALOX5CDC14BCDC14AWEE1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230131749-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230131749-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230131749-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CYP1A1, CYP1B1 | ALOX5 611/4885CDC14B 3791/4885CDC14A 3829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.